Population
Patients with anterior circulation large vessel occlusion presenting 24-96 hours after onset
Comparison
Endovascular treatment vs medical management
Follow-up
90 days
Answers are grounded in this paper and cite their sources.
Retrospective cohort study demonstrates endovascular treatment improves 90-day functional independence in late-presenting stroke, suggesting a wider therapeutic window for thrombectomy.
Background The role of endovascular treatment (EVT) in acute ischemic stroke (AIS) from 24 to 96 hours after symptom onset remains uncertain. Purpose To evaluate the functional and safety outcomes of EVT versus best medical management (BMM) in patients with AIS due to large vessel occlusion (LVO) presenting greater than 24 hours to 96 hours (hereafter "24-96 hours") after symptom onset. Materials and Methods Prospectively maintained stroke registries from eight stroke centers in China (September 2020-January 2025) were analyzed in this retrospective cohort study. Patients with intracranial internal carotid artery or M1 or M2 middle cerebral artery occlusion, National Institutes of Health Stroke Scale score of 6 or higher, and Alberta Stroke Program Early CT Score of 3 or higher who presented 24-96 hours after onset were included, grouped by treatment (EVT vs BMM alone), and followed for 90 days. The primary outcome was functional independence (modified Rankin Scale score of 0-2) at 90 days. Secondary safety outcomes included symptomatic intracranial hemorrhage and 90-day mortality. Outcomes were compared using multivariable logistic regression and inverse probability of treatment weighting (IPTW), adjusted for demographic and clinical variables. Results Among 308 patients (mean age, 67 years ± 12 [SD]; 202 men), 205 underwent EVT and 103 received BMM. Functional independence at 90 days was more frequent with EVT than BMM (50.7% [104 of 205] vs 28.2% [29 of 103]; P < .001). After multivariable adjustment, the odds ratio (OR) for functional independence with EVT compared with BMM was 3.8 (95% CI: 2.1, 6.8; P < .001); after IPTW adjustment, the OR was 4.4 (95% CI: 2.4, 8.1; P < .001). After multivariable adjustment, the incidence of symptomatic intracranial hemorrhage (5.9% vs 2.9%; OR, 2.2 [95% CI: 0.6, 8.2]; P = .26) and 90-day mortality (11.2% vs 13.6%; OR, 0.6 [95% CI: 0.3, 1.4]; P = .22) did not differ between the EVT and BMM groups. Conclusion Among Chinese patients with AIS due to LVO presenting 24-96 hours after symptom onset, EVT was associated with improved functional outcomes, without clear increases in mortality or symptomatic intracranial hemorrhage.
No takes yet. Share an insight, caveat, or question.
Yi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: